Orleans Capital Management Corp LA Sells 1,237 Shares of Becton Dickinson and Co (BDX)

Orleans Capital Management Corp LA decreased its stake in shares of Becton Dickinson and Co (NYSE:BDX) by 5.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 19,798 shares of the medical instruments supplier’s stock after selling 1,237 shares during the quarter. Becton Dickinson and comprises 2.9% of Orleans Capital Management Corp LA’s holdings, making the stock its 3rd biggest position. Orleans Capital Management Corp LA’s holdings in Becton Dickinson and were worth $3,879,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of BDX. Mitsubishi UFJ Securities Holdings Co. Ltd. grew its position in Becton Dickinson and by 55.8% during the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 670 shares of the medical instruments supplier’s stock valued at $131,000 after buying an additional 240 shares during the period. Parkside Financial Bank & Trust grew its position in Becton Dickinson and by 8.1% during the second quarter. Parkside Financial Bank & Trust now owns 684 shares of the medical instruments supplier’s stock valued at $133,000 after buying an additional 51 shares during the period. Harfst & Associates Inc. grew its position in Becton Dickinson and by 46.4% during the second quarter. Harfst & Associates Inc. now owns 697 shares of the medical instruments supplier’s stock valued at $135,000 after buying an additional 221 shares during the period. Harvest Fund Management Co. Ltd grew its position in Becton Dickinson and by 82.8% during the second quarter. Harvest Fund Management Co. Ltd now owns 746 shares of the medical instruments supplier’s stock valued at $146,000 after buying an additional 338 shares during the period. Finally, Acrospire Investment Management LLC lifted its holdings in Becton Dickinson and by 259.7% during the second quarter. Acrospire Investment Management LLC now owns 831 shares of the medical instruments supplier’s stock valued at $162,000 after purchasing an additional 600 shares in the last quarter. Institutional investors and hedge funds own 87.72% of the company’s stock.

Becton Dickinson and Co (NYSE:BDX) traded down $0.26 during trading hours on Friday, hitting $214.06. 1,649,421 shares of the stock were exchanged, compared to its average volume of 1,168,412. The company has a debt-to-equity ratio of 1.44, a quick ratio of 5.03 and a current ratio of 5.58. Becton Dickinson and Co has a fifty-two week low of $161.50 and a fifty-two week high of $229.68. The firm has a market cap of $49,166.68, a PE ratio of 46.03, a PEG ratio of 1.68 and a beta of 1.07.

Becton Dickinson and (NYSE:BDX) last posted its quarterly earnings results on Thursday, November 2nd. The medical instruments supplier reported $2.40 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.37 by $0.03. Becton Dickinson and had a net margin of 8.52% and a return on equity of 20.56%. The business had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.14 billion. During the same period in the prior year, the company posted $2.12 EPS. The business’s revenue for the quarter was down 2.0% on a year-over-year basis. analysts forecast that Becton Dickinson and Co will post 10.64 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 29th. Investors of record on Friday, December 8th were given a $0.75 dividend. The ex-dividend date of this dividend was Thursday, December 7th. This is a positive change from Becton Dickinson and’s previous quarterly dividend of $0.73. This represents a $3.00 annualized dividend and a dividend yield of 1.40%. Becton Dickinson and’s payout ratio is currently 64.52%.

Several equities analysts have issued reports on BDX shares. Piper Jaffray Companies restated a “buy” rating and set a $213.00 price objective on shares of Becton Dickinson and in a research report on Tuesday, September 12th. Royal Bank of Canada restated a “hold” rating and set a $210.00 price objective on shares of Becton Dickinson and in a research report on Wednesday, October 25th. Morgan Stanley lifted their price target on shares of Becton Dickinson and from $205.00 to $245.00 and gave the company an “equal weight” rating in a research report on Friday, November 3rd. Zacks Investment Research cut shares of Becton Dickinson and from a “hold” rating to a “sell” rating in a research report on Monday, October 9th. Finally, Stifel Nicolaus restated a “buy” rating and issued a $245.00 price objective on shares of Becton Dickinson and in a report on Friday, November 3rd. Four research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $221.13.

TRADEMARK VIOLATION WARNING: “Orleans Capital Management Corp LA Sells 1,237 Shares of Becton Dickinson and Co (BDX)” was first reported by Week Herald and is owned by of Week Herald. If you are viewing this report on another website, it was copied illegally and republished in violation of United States and international copyright law. The correct version of this report can be viewed at https://weekherald.com/2017/12/30/becton-dickinson-and-co-bdx-shares-sold-by-orleans-capital-management-corp-la.html.

Becton Dickinson and Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Institutional Ownership by Quarter for Becton Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply